Literature DB >> 2614429

Changes within the "normal" cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI.

M Brainin1, A Neuhold, T Reisner, E Maida, S Lang, L Deecke.   

Abstract

Changes in the apparently unaffected cerebral white matter of multiple sclerosis (MS) patients were studied during acute attacks as well as during high-dose prednisolone therapy. Serial MR scans of patients with a clinically definite diagnosis were performed on four defined occasions: before an episode, within three days after its onset, after 10 days of therapy as well as four weeks later. Thirteen patients agreed to cooperate in forming a MRI data base and to be rescanned immediately after the onset of an acute relapse. Within one year, six patients had such episodes, one of them had a second bout. Both T1 and T2 relaxation times within the apparently normal white matter were significantly prolonged in all cerebral lobes compared to a control group of healthy volunteers. During the acute attacks as well as during therapy the T1 values remained as before. The T2 values were elevated only in two out of six cases during the episode. After therapy a considerable clinical improvement was seen in all cases, but a significant T2 decrease as a possible effect of cortisone was noted in only one case. We conclude that the prolonged relaxation times T1 and T2 within the apparently normal cerebral white matter of MS patients are the result of a number of molecular events differing considerably among individual patients and that serial measurements of these relaxation times do not consistently change during an acute relapse and do not reflect clinical improvement after high dose prednisolone therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2614429      PMCID: PMC1031591          DOI: 10.1136/jnnp.52.12.1355

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  Biologic versus clinical MS.

Authors:  D W Paty; K A Eisen; J J Oger; S J Purves; L F Kastrukoff; M Low; S A Hashimoto; V Brandjes; J J Hooge; W Robertson
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

2.  Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone.

Authors:  J Kesselring; D H Miller; D G MacManus; G Johnson; N M Milligan; N Scolding; D A Compston; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

3.  [Involvement of apparently normal white brain substance in the disease process of multiple sclerosis].

Authors:  M Brainin; T Reisner; A Neuhold; S Lang; L Deecke
Journal:  Nervenarzt       Date:  1989-03       Impact factor: 1.214

4.  RLSQ: T1, T2, and rho calculations, combining ratios and least squares.

Authors:  J J In den Kleef; J J Cuppen
Journal:  Magn Reson Med       Date:  1987-12       Impact factor: 4.668

5.  A method for the clinical measurement of relaxation times in magnetic resonance imaging.

Authors:  D S Hickey; D Checkley; R M Aspden; A Naughton; J P Jenkins; I Isherwood
Journal:  Br J Radiol       Date:  1986-06       Impact factor: 3.039

6.  In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis.

Authors:  H B Larsson; J Frederiksen; L Kjaer; O Henriksen; J Olesen
Journal:  Magn Reson Med       Date:  1988-05       Impact factor: 4.668

7.  Biomedical implications of the relaxation behaviour of water related to NMR imaging.

Authors:  R Mathur-De Vré
Journal:  Br J Radiol       Date:  1984-11       Impact factor: 3.039

8.  Relaxation times of apparently normal cerebral white matter in multiple sclerosis.

Authors:  I E Ormerod; G Johnson; D MacManus; E P du Boulay; W I McDonald
Journal:  Acta Radiol Suppl       Date:  1986

9.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.

Authors:  D H Miller; P Rudge; G Johnson; B E Kendall; D G Macmanus; I F Moseley; D Barnes; W I McDonald
Journal:  Brain       Date:  1988-08       Impact factor: 13.501

10.  Spin-lattice relaxation (T1) times of cerebral white matter in multiple sclerosis.

Authors:  D Lacomis; M Osbakken; G Gross
Journal:  Magn Reson Med       Date:  1986-04       Impact factor: 4.668

View more
  3 in total

1.  A diffusion longitudinal MR imaging study in normal-appearing white matter in untreated relapsing-remitting multiple sclerosis.

Authors:  F G Garaci; V Colangelo; A Ludovici; F Gaudiello; S Marziali; D Centonze; L Boffa; G Simonetti; R Floris
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

2.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Authors:  D H Miller; F Barkhof; I Berry; L Kappos; G Scotti; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

3.  Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis.

Authors:  M Siger-Zajdel; K Selmaj
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.